The first clinical guidance for cardiogenic shock will be presented at the American College of Cardiology Scientific Session ...

Johnson & Johnson MedTech, the global leader in heart recovery, will feature the latest evidence demonstrating the survival benefit of Impella® heart pump technology at the American College of ...

Recently, however, the DanGer Shock trial delivered a decisively positive result for Impella in highly selected patients with STEMI complicated by cardiogenic shock. On the strength of that trial, the ...

Sunil Rao Another noteworthy addition is a class 2a recommendation stating that use of a microaxial intravascular flow pump—like the Impella CP device (Abiomed ... with STEMI and severe or refractory ...

In a transformative recent study, the Second Heart Assist Inc. Whispertm device, a next-generation percutaneous mechanical circulatory support (pMCS) system, was shown to cause significantly less ...

As Healio previously reported, routine use of a microaxial flow pump (Impella CP ... care alone for patients with STEMI and cardiogenic shock. The class IIA guideline recommendation is specific ...

In that window, Gresham suffered cardiogenic shock, prompting Thota to utilize a small catheter called the Impella. “We are fortunate we have the latest technology in United Regional,” Thota said.

The recent study by Holger Thiele and colleagues 1 offers an extensive meta-analysis on the use of mechanical circulatory support (MCS) in acute myocardial infarction-related cardiogenic shock (AMICS ...

Dublin, March 13, 2025 (GLOBE NEWSWIRE) -- The "Cardiogenic Shock Market: Analysis by Treatment Type, End User, and Region - Growth Trends and Forecast to 2030" report has been added to ...

The following is a summary of “ICU mortality of post-myocardial infarction ventricular septal defect complicated by ...